Case number 2017-1594
Yeda Research and Development v. Mylan Pharmaceuticals Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | YEDA RESEARCH AND DEVELOPMENT v. MYLAN PHARMACEUTICALS INC. [OPINION] [precedential] (0) |
| Nov 20, 2018 | 70 | Mandate issued to the United States Patent and Trademark Office. Service as of this date by the Clerk of Court. [566660] [17-1594, 17-1595, 17-1596] [PBC] [Entered: 11/20/2018 10:58 AM] (0) |
| Oct 12, 2018 | 68 | OPINION filed for the court by Reyna, Circuit Judge; Bryson, Circuit Judge and Stoll, Circuit Judge. Precedential Opinion. [556571] [17-1594, 17-1595, 17-1596] [PBC] [Entered: 10/12/2018 09:53 AM] (0) |
| Oct 12, 2018 | 69 | JUDGMENT filed. AFFIRMED. Terminated on the merits after oral argument. COSTS: No Costs. Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [556599] [17-1594, 17-1595, 17-1596] [PBC] [Entered: 10/12/2018 10:22 AM] (0) |
| May 1, 2018 | 67 | Submitted after ORAL ARGUMENT by William M. Jay for Yeda Research and Development Co., Ltd. and David Lee Anstaett for Mylan Pharmaceuticals Inc. and Amneal Pharmaceuticals LLC. Panel: Judge: Reyna , Judge: Bryson , Judge: Stoll. [518014] [JAB] [Entered: 05/01/2018 10:53 AM] (0) |
| Apr 27, 2018 | 66 | Clerk's Letter to Appellant Yeda Research and Development Co., Ltd. and Appellees Amneal Pharmaceuticals LLC and Mylan Pharmaceuticals Inc. (regarding Supreme Court decision in SAS Institute). Service as of this date by the Clerk of Court. [517507] [SJ] [Entered: 04/27/2018 04:47 PM] (0) |
| Apr 18, 2018 | 64 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:calendar response Docket No. [63], ERROR: Counsel for appellee Amneal Pharmaceuticals LLC filed a response to the oral argument order "Designating Counsel for Mylan Pharmaceuticals Inc. will be arguing on behalf of all appellees to argue". This is not an acceptable response. Counsel must indicate which attorney will argue for the party and for how much time. CORRECTION: Please promptly file a corrected response. [514687] [JAB] [Entered: 04/18/2018 08:54 AM] (0) |
| Apr 18, 2018 | 65 | CORRECTED Response to oral argument order from the Appellee Amneal Pharmaceuticals LLC. Designating David L. Anstaett to argue.. Designating 15 minutes for argument. [17-1594] [Anthony Fitzpatrick] [Entered: 04/18/2018 01:25 PM] (0) |
| Apr 17, 2018 | 62 | Notice to counsel for Appellee Amneal Pharmaceuticals LLC: The record of this case indicates that the response to the oral argument order has not been filed. The response was due on or before 04/16/2018. Counsel should promptly docket the Response to Oral Argument Order event and designate which attorney will present argument for the party. Service as of this date by the Clerk of Court. [514082] [JAB] [Entered: 04/17/2018 12:02 PM] (0) |
| Apr 17, 2018 | 63 | Response to oral argument order from the Appellee Amneal Pharmaceuticals LLC. Designating Counsel for Mylan Pharmaceuticals Inc. will be arguing on behalf of all appellees to argue. [17-1594] [Anthony Fitzpatrick] [Entered: 04/17/2018 03:51 PM] (0) |
| Apr 16, 2018 | 61 | Response to oral argument order from the Appellant Yeda Research and Development Co., Ltd.. Designating William M. Jay to argue.. Designating 11 minutes for argument. Reserving 4 minutes for rebuttal. [17-1594] [William Jay] [Entered: 04/16/2018 05:43 PM] (0) |
| Apr 16, 2018 | 60 | Response to oral argument order from the Appellee Mylan Pharmaceuticals Inc.. Designating David L. Anstaett to argue.. Designating 15 minutes for argument. [17-1594] [Dan Bagatell] [Entered: 04/16/2018 03:53 PM] (0) |
| Mar 22, 2018 | 59 | NOTICE OF CALENDARING. Panel: 1805G. Case scheduled May 01, 2018 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, NW Washington, DC 20439), Courtroom 203. Response to oral argument order due: 04/16/2018. Arguing counsel is required to check-in with the Clerk's Office, 4th Floor, Room 401, between 8:30 a.m. and 9:30 a.m. on the day of argument. Please review the Oral Argument Order. [507296] [JAB] [Entered: 03/22/2018 04:33 PM] (0) |
| Mar 21, 2018 | 58 | Notice from Appellant Yeda Research and Development Co., Ltd. regarding conflicts with oral argument (Unavailable May 4, in addition to conflicts identified in previous letters). Service: 03/21/2018 by email. [506968] [17-1594] [John O'Quinn] [Entered: 03/21/2018 05:06 PM] (3) |
| Mar 6, 2018 | 57 | Notice from Appellant Yeda Research and Development Co., Ltd. regarding conflicts with oral argument ([update from 1/29/2018 ltr]: request not to schedule argument May 2-3, June 5, June 7, or during same session as nos. 17-1094, 17-1744, 17-2490, 17-2173, or 17-2106). Service: 03/06/2018 by email. [502946] [John O'Quinn] [Entered: 03/06/2018 04:32 PM] (2) |
| Jan 29, 2018 | 56 | Notice from Appellant Yeda Research and Development Co., Ltd. regarding conflicts with oral argument ([updated from 12/6/2017 ltr] request not to schedule argument April 2-9, or during same session as nos. 17-1094, 17-1784, 17-1744, or 17-2173). Service: 01/29/2018 by email. [493256] [John O'Quinn] [Entered: 01/29/2018 10:19 AM] (2) |
| Dec 6, 2017 | 55 | Notice from Appellant Yeda Research and Development Co., Ltd. regarding conflicts with oral argument ([updated from 11/14 ltr]: request not to schedule argument in February 2018, Mar. 8, April 5 or 9, or during the same argument session as nos. 17-1094, 17-1131, 17-1784, 17-1525, 17-1798, or 17-2173). Service: 12/06/2017 by email. [480591] [John O'Quinn] [Entered: 12/06/2017 12:58 PM] (3) |
| Nov 14, 2017 | 54 | Notice from Appellant Yeda Research and Development Co., Ltd. regarding conflicts with oral argument ([updated from 10/17/17 ltr]: request not to schedule argument January 11-12, February 7-9, March 8, April 5 or during same week as No. 17-1094, 17-1131, 17-1525, 17-1784, or 17-1798). Service: 11/14/2017 by email. [475518] [John O'Quinn] [Entered: 11/14/2017 05:24 PM] (2) |
| Oct 17, 2017 | 53 | Notice from Appellant Yeda Research and Development Co., Ltd. regarding conflicts with oral argument (December 7-8, January 11-12, February 7-9, March 8, April 5; request not to schedule argument same week as nos. 15-2021, 17-1094, 17-1131, or 17-1798). Service: 10/17/2017 by email. [468633] [John O'Quinn] [Entered: 10/17/2017 08:11 PM] (2) |
| Oct 17, 2017 | 52 | 6 paper copies of the Joint Appendix (Vols. I-III) [49] received from Appellant Yeda Research and Development Co., Ltd. [468549] [CW] [Entered: 10/17/2017 04:05 PM] (0) |
| Oct 10, 2017 | 51 | 6 paper copies of the Reply Brief [47] received from Appellant Yeda Research and Development Co., Ltd. [466450] [CW] [Entered: 10/10/2017 11:36 AM] (0) |
| Oct 10, 2017 | 50 | Pursuant to Practice Note 34, counsel should advise the clerk of court of scheduling conflicts for the next three court weeks, or thereafter. When filing the notice of conflicts, counsel should docket the Notice Regarding Conflicts with Argument Dates event, which is found in the Calendar event category.. [466389] [SJ] [Entered: 10/10/2017 10:14 AM] (0) |
| Oct 6, 2017 | 49 | APPENDIX FILED for Yeda Research and Development Co., Ltd. [48]. Number of Pages: 1955. Service: 10/06/2017 by email. The paper copies of the brief should be received by the court on or before 10/17/2017. [466387] [SJ] [Entered: 10/10/2017 10:14 AM] (1961) |
| Oct 6, 2017 | 48 | TENDERED from Appellant Yeda Research and Development Co., Ltd.. Title: JOINT APPENDIX. Service: 10/06/2017 by email. [466283] [John O'Quinn] [Entered: 10/06/2017 10:09 PM] (1961) |
| Sep 29, 2017 | 47 | REPLY BRIEF FILED for Appellant Yeda Research and Development Co., Ltd. [46]. Number of Pages: 37. Service: 09/29/2017 by email. The paper copies of the brief should be received by the court on or before 10/11/2017. Appendix is due 10/06/2017. [465065] [SJ] [Entered: 10/03/2017 11:42 AM] (46) |
| Sep 29, 2017 | 46 | TENDERED from Appellant Yeda Research and Development Co., Ltd.. Title: REPLY BRIEF. Service: 09/29/2017 by email. [464528] [John O'Quinn] [Entered: 09/29/2017 08:38 PM] (46) |
| Aug 25, 2017 | 45 | **TEXT ONLY** ORDER granting motion to extend time to file reply brief [44] filed by Appellant Yeda Research and Development Co., Ltd. Reply brief is due 09/29/2017. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [456626] [SJ] [Entered: 08/25/2017 11:17 AM] (0) |
| Aug 24, 2017 | 44 | MOTION of Appellant Yeda Research and Development Co., Ltd. to extend the time to 09/29/2017 to file the reply brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 08/24/2017 by email. [456512] [John O'Quinn] [Entered: 08/24/2017 07:06 PM] (9) |
| Aug 24, 2017 | 43 | 6 paper copies of the Opening Response Brief [42] received from Appellees Amneal Pharmaceuticals LLC and Mylan Pharmaceuticals Inc. [456320] [CW] [Entered: 08/24/2017 11:10 AM] (0) |
| Aug 18, 2017 | 42 | BRIEF FILED for Appellees Amneal Pharmaceuticals LLC and Mylan Pharmaceuticals Inc. [41]. Number of Pages: 62. Service: 08/18/2017 by email. The paper copies of the brief should be received by the court on or before 08/28/2017. Appellant Yeda Research and Development Co., Ltd. reply brief is due 09/01/2017. [455330] [SJ] [Entered: 08/21/2017 11:39 AM] (77) |
| Aug 18, 2017 | 41 | TENDERED from Appellees Amneal Pharmaceuticals LLC and Mylan Pharmaceuticals Inc.. Title: RESPONSE BRIEF. Service: 08/18/2017 by email. [455206] [Dan Bagatell] [Entered: 08/18/2017 04:22 PM] (77) |
| Jul 11, 2017 | 40 | RESPONSE of Appellee Mylan Pharmaceuticals Inc. to the supplemental authority [34] filed by Appellant Yeda Research and Development Co., Ltd. in 17-1594. Service: 07/11/2017 by email. [445517] [Dan Bagatell] [Entered: 07/11/2017 10:26 AM] (2) |
| Jul 11, 2017 | 39 | NOTICE OF DEFICIENCY: The supplemental authority Document No. [38] filed by Appellee Mylan Pharmaceuticals Inc. in 17-1594 is submitted using the incorrect event and therefore cannot be accepted for filing at this time. You are being afforded the opportunity to correct the deficiency [resubmit using event 'response/opposition to other document']. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [445514] [SJ] [Entered: 07/11/2017 10:17 AM] (0) |
| Jul 10, 2017 | 38 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Appellee Mylan Pharmaceuticals Inc.. Service: 07/10/2017 by email. [445442] [Dan Bagatell] [Entered: 07/10/2017 10:21 PM] (0) |
| Jul 7, 2017 | 37 | **TEXT ONLY** ORDER granting motion to extend time to file appellees' principal brief(s) [35] filed by Appellees Mylan Pharmaceuticals Inc. and Amneal Pharmaceuticals LLC. Appellees Amneal Pharmaceuticals LLC and Mylan Pharmaceuticals Inc. brief(s) due 08/18/2017. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [445002] [SJ] [Entered: 07/07/2017 04:28 PM] (0) |
| Jul 7, 2017 | 36 | Entry of appearance for Christina J. McCullough as of counsel for Appellee Mylan Pharmaceuticals Inc.. Service: 07/07/2017 by email. [444822] [Christina McCullough] [Entered: 07/07/2017 12:25 PM] (2) |
| Jul 6, 2017 | 35 | MOTION of Appellees Amneal Pharmaceuticals LLC and Mylan Pharmaceuticals Inc. to extend the time to 08/18/2017 at 11:59 pm to file the appellee/respondent/cross-appellant's principal brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 07/06/2017 by email. [444665] [Dan Bagatell] [Entered: 07/06/2017 08:26 PM] (7) |
| Jun 19, 2017 | 34 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Appellant Yeda Research and Development Co., Ltd.. Service: 06/19/2017 by email. [440547] [John O'Quinn] [Entered: 06/19/2017 05:40 PM] (2) |
| Jun 14, 2017 | 33 | 6 paper copies of the Opening Brief [32] received from Appellant Yeda Research and Development Co., Ltd. [439184] [JCP] [Entered: 06/14/2017 12:33 PM] (0) |
| Jun 7, 2017 | 31 | Entry of appearance for William G. James II as of counsel for Appellant Yeda Research and Development Co., Ltd.. Service: 06/07/2017 by email. [437331] [William James] [Entered: 06/07/2017 06:00 PM] (2) |
| Jun 6, 2017 | 30 | TENDERED from Appellant Yeda Research and Development Co., Ltd.. Title: OPENING BRIEF. Service: 06/06/2017 by email. [436909] [John O'Quinn] [Entered: 06/06/2017 07:56 PM] (249) |
| Jun 6, 2017 | 32 | BRIEF FILED for Appellant Yeda Research and Development Co., Ltd. [30]. Number of Pages: 71. Service: 06/06/2017 by email. The paper copies of the brief should be received by the court on or before 06/15/2017. Appellees Amneal Pharmaceuticals LLC and Mylan Pharmaceuticals Inc. brief is due 07/17/2017. [437384] [SJ] [Entered: 06/08/2017 08:58 AM] (249) |
| May 15, 2017 | 29 | Entry of appearance for Leslie M. Schmidt as of counsel for Appellant Yeda Research and Development Co., Ltd.. Service: 05/15/2017 by email. [431581] [Leslie Schmidt] [Entered: 05/15/2017 04:46 PM] (2) |
| Apr 18, 2017 | 28 | Amended Certificate of Interest for the Appellee Mylan Pharmaceuticals Inc.. Service: 04/18/2017 by email. [425219] [Shannon Bloodworth] [Entered: 04/18/2017 03:28 PM] (3) |
| Apr 10, 2017 | 26 | MOTION of Appellant Yeda Research and Development Co., Ltd. to extend the time to 06/06/2017 to file the appellant/petitioner's principal brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 04/10/2017 by email. [422757] [William Burgess] [Entered: 04/10/2017 01:28 PM] (7) |
| Apr 10, 2017 | 27 | **TEXT ONLY** ORDER granting motion to extend time to file appellant's principal brief [26] filed by Appellant Yeda Research and Development Co., Ltd. The brief is due 06/06/2017. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [422763] [MJL] [Entered: 04/10/2017 01:38 PM] (0) |
| Mar 20, 2017 | 25 | Certified list from the United States Patent and Trademark Office. Service: 03/20/2017 by email. Appellants brief is due 05/19/2017. [417000] [17-1594, 17-1595, 17-1596] [SJ] [Entered: 03/20/2017 01:26 PM] (182) |
| Mar 1, 2017 | 24 | ORDER filed. Appeal Nos. 2017-1575 and 2017-1594, -1595, -1596 shall be considered companion cases and assigned to the same merits panel. Service: 03/01/2017 by clerk. [411686] [17-1575, 17-1594] [LMS] [Entered: 03/01/2017 02:32 PM] (2) |
| Feb 22, 2017 | 23 | Entry of appearance for John C. O'Quinn as principal counsel for Appellant Yeda Research and Development Co., Ltd.. Service: 02/22/2017 by email. [409824] [John O'Quinn] [Entered: 02/22/2017 07:07 PM] (2) |
| Feb 22, 2017 | 22 | Entry of appearance for Daryl L. Wiesen as of counsel for Appellant Yeda Research and Development Co., Ltd.. Service: 02/22/2017 by email. [409821] [Daryl Wiesen] [Entered: 02/22/2017 06:41 PM] (2) |
| Feb 22, 2017 | 21 | Entry of appearance for Elizabeth J. Holland as of counsel for Appellant Yeda Research and Development Co., Ltd.. Service: 02/22/2017 by email. [409820] [Elizabeth Holland] [Entered: 02/22/2017 06:37 PM] (2) |
| Feb 22, 2017 | 20 | Docketing Statement for the Appellant Yeda Research and Development Co., Ltd.. Service: 02/22/2017 by email. [409818] [William Jay] [Entered: 02/22/2017 06:32 PM] (3) |
| Feb 22, 2017 | 19 | Certificate of Interest for the Appellant Yeda Research and Development Co., Ltd.. Service: 02/22/2017 by email. [409817] [William Jay] [Entered: 02/22/2017 06:30 PM] (3) |
| Feb 22, 2017 | 18 | Entry of appearance for William M. Jay as of counsel for Appellant Yeda Research and Development Co., Ltd.. Service: 02/22/2017 by email. [409815] [William Jay] [Entered: 02/22/2017 06:27 PM] (2) |
| Feb 22, 2017 | 17 | Entry of appearance for Robert D. Swanson as of counsel for Appellee Mylan Pharmaceuticals Inc.. Service: 02/22/2017 by email. [409803] [Robert Swanson] [Entered: 02/22/2017 05:18 PM] (2) |
| Feb 22, 2017 | 16 | Entry of appearance for Brandon M. White as of counsel for Appellee Mylan Pharmaceuticals Inc.. Service: 02/22/2017 by email. [409802] [Robert Swanson] [Entered: 02/22/2017 05:17 PM] (2) |
| Feb 21, 2017 | 15 | Entry of appearance for David L. Anstaett as of counsel for Appellee Mylan Pharmaceuticals Inc.. Service: 02/21/2017 by email. [409402] [Dan Bagatell] [Entered: 02/21/2017 06:13 PM] (2) |
| Feb 21, 2017 | 14 | Entry of appearance for Dan L. Bagatell as of counsel for Appellee Mylan Pharmaceuticals Inc.. Service: 02/21/2017 by email. [409401] [Dan Bagatell] [Entered: 02/21/2017 06:11 PM] (2) |
| Feb 21, 2017 | 13 | Docketing Statement for the Appellee Mylan Pharmaceuticals Inc.. Service: 02/21/2017 by email. [409397] [Shannon Bloodworth] [Entered: 02/21/2017 06:04 PM] (4) |
| Feb 21, 2017 | 12 | Certificate of Interest for the Appellee Mylan Pharmaceuticals Inc.. Service: 02/21/2017 by email. [409393] [Shannon Bloodworth] [Entered: 02/21/2017 06:03 PM] (3) |
| Feb 21, 2017 | 11 | Entry of appearance for Shannon M. Bloodworth as principal counsel for Appellee Mylan Pharmaceuticals Inc.. Service: 02/21/2017 by email. [409390] [Shannon Bloodworth] [Entered: 02/21/2017 06:02 PM] (2) |
| Feb 21, 2017 | 10 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: ERROR: Christopher S. Kroon (entry of appearance [5]) is not a registered CM/ECF filer with the Federal Circuit. CORRECTION: Pursuant to FCR 25(a)(2), attorneys who appear before this court must register for the court's CM/ECF system. Please register promptly. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [409356] [CMP] [Entered: 02/21/2017 04:39 PM] (0) |
| Feb 21, 2017 | 9 | Entry of appearance for Vincent L. Capuano as of counsel for Appellee Amneal Pharmaceuticals LLC. Service: 02/21/2017 by email. [409315] [Vincent Capuano] [Entered: 02/21/2017 04:13 PM] (1) |
| Feb 21, 2017 | 8 | Docketing Statement for the Appellee Amneal Pharmaceuticals LLC. Service: 02/21/2017 by email. [409306] [Anthony Fitzpatrick] [Entered: 02/21/2017 04:08 PM] (4) |
| Feb 21, 2017 | 7 | Certificate of Interest for the Appellee Amneal Pharmaceuticals LLC. Service: 02/21/2017 by email. [409305] [Anthony Fitzpatrick] [Entered: 02/21/2017 04:07 PM] (1) |
| Feb 21, 2017 | 6 | Entry of appearance for Patrick C. Gallagher as of counsel for Appellee Amneal Pharmaceuticals LLC. Service: 02/21/2017 by email. [409303] [Anthony Fitzpatrick] [Entered: 02/21/2017 04:05 PM] (1) |
| Feb 21, 2017 | 5 | Entry of appearance for Christopher S. Kroon as of counsel for Appellee Amneal Pharmaceuticals LLC. Service: 02/21/2017 by email. [409302] [Anthony Fitzpatrick] [Entered: 02/21/2017 04:04 PM] (1) |
| Feb 21, 2017 | 4 | Entry of appearance for Anthony J. Fitzpatrick as principal counsel for Appellee Amneal Pharmaceuticals LLC. Service: 02/21/2017 by email. [409298] [Anthony Fitzpatrick] [Entered: 02/21/2017 04:01 PM] (1) |
| Feb 13, 2017 | 3 | Note to file: The following cases are associated:17-1594 (lead) with 17-1595 & 17-1596 (consolidated). FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [406978] [17-1594, 17-1595, 17-1596] [SJ] [Entered: 02/13/2017 03:50 PM] (0) |
| Feb 13, 2017 | 2 | ORDER consolidating appeals. Service as of this date by Clerk of Court. [406968] [17-1594, 17-1595, 17-1596] [SJ] [Entered: 02/13/2017 03:43 PM] (2) |
| Feb 8, 2017 | 1 | Appeal docketed. Received: 02/01/2017. [405513] Entry of Appearance due 02/22/2017. Certificate of Interest is due on 02/22/2017. Docketing Statement due 02/22/2017. Certified List due on 03/20/2017. [SJ] [Entered: 02/08/2017 09:42 AM] (47) |
